Congo vs Hong Kong: The number of people with susceptibility test result for rifampicin
Congo
2,015
in 2021
Hong Kong
2,181
in 2021
Congo rank
47th
Hong Kong rank
45th
The number of people with susceptibility test result for rifampicin over time
- Congo
- Hong Kong
How they compare
Hong Kong currently reports 2,181 against 2,015 in Congo, a difference of 166.
That makes Hong Kong's figure about 1.1 times Congo's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Hong Kong ahead.
Congo ranks 47th and Hong Kong ranks 45th of 155 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Hong Kong in 1.
Head to head by decade
| Decade | Congo | Hong Kong | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 621 | 2,387 | 1,766 | Hong Kong |
| 2020s | 3,055 | 2,143 | 912 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo or Hong Kong?
- Hong Kong, at 2,181 against 2,015 in Congo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo and Hong Kong?
- 166, with Hong Kong ahead.
- How many years of comparable data are there for Congo and Hong Kong?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo and Hong Kong rank globally for the number of people with susceptibility test result for rifampicin?
- Congo ranks 47th and Hong Kong ranks 45th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.